Cancer Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Lung Cancer
Emerging Clinical Data Continues to Support CyberKnife Radiosurgery for the Treatment of Lung Cancer
August 26th, 2008
Accuray Incorporated (NASDAQ:ARAY), a global leader in the field of radiosurgery, announced that emerging clinical data continues to support CyberKnife radiosurgery for the treatment of lung cancer, following a study published in the July 2008 issue of Clinical Lung Cancer. As scientific evidence mounts, physician usage and patient demand are increasing dramatically -- over the past 12 month period, the number of lung patients treated with the CyberKnife System has grown by nearly 50 percent and more than 6,000 lung cancer patients have been treated to date. The study, titled "Fractionated Stereotactic Body Radiation Therapy in the Treatment of Primary, Recurrent, and...
Source: Cancer Weekly (2008-08-26)
|
